Establishment Labs Holdings Inc. (ESTA) Current Ratio
- Current ratio · latest quarter: Value 3.84×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 3.84× | Current assets / current liabilities. $247.73M ÷ $64.56M ≈ 3.84× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 247.73M USD | Assets, Current |
| Current obligations | 64.56M USD | Liabilities, Current |
| Cash and equivalents | 71.16M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 75.65M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 84.98M USD | Inventory, Net |
| Payables | 32.84M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $247.73M | $64.56M | $71.16M | (m) | $75.65M | $84.98M | $32.84M | (m) | 3.84× |
| 2026-03-31 | $245.83M | $83.15M | $68.10M | (m) | $77.08M | $86.66M | $41.81M | (m) | 2.96× |
| 2025-12-31 | $249.94M | $82.14M | $75.57M | (m) | $77.50M | $85.61M | $43.11M | (m) | 3.04× |
| 2025-09-30 | $239.60M | $71.98M | $70.62M | (m) | $71.44M | $88.16M | $39.72M | (m) | 3.33× |
| 2025-06-30 | $229.17M | $80.74M | $54.64M | (m) | $70.09M | $94.68M | $55.81M | (m) | 2.84× |
| 2025-03-31 | $231.70M | $69.04M | $69.18M | (m) | $63.24M | $90.42M | $45.19M | (m) | 3.36× |
| 2024-12-31 | $243.04M | $68.28M | $90.35M | (m) | $65.00M | $78.77M | $44.76M | (m) | 3.56× |
| 2024-09-30 | $182.95M | $50.50M | (m) | (m) | $67.25M | $67.12M | $34.40M | (m) | 3.62× |
| 2024-06-30 | $186.13M | $41.89M | (m) | (m) | $59.98M | $64.21M | $28.42M | (m) | 4.44× |
| 2024-03-31 | $203.69M | $48.02M | (m) | (m) | $50.84M | $72.49M | $31.07M | (m) | 4.24× |
| 2023-12-31 | $174.90M | $57.15M | $40.03M | (m) | $46.92M | $79.47M | $41.62M | (m) | 3.06× |
| 2023-09-30 | $186.72M | $50.30M | (m) | (m) | $54.69M | $67.94M | $28.93M | (m) | 3.71× |
| 2023-06-30 | $209.02M | $43.27M | (m) | (m) | $51.40M | $56.37M | $24.36M | (m) | 4.83× |
| 2023-03-31 | $142.04M | $41.47M | (m) | (m) | $41.05M | $46.14M | $20.25M | (m) | 3.43× |
| 2022-12-31 | $149.90M | $38.96M | $66.36M | (m) | $35.42M | $36.58M | $20.03M | (m) | 3.85× |
| 2022-09-30 | $138.16M | $32.38M | (m) | (m) | $31.25M | $31.56M | $14.88M | (m) | 4.27× |
| 2022-06-30 | $156.43M | $34.75M | (m) | (m) | $32.00M | $26.53M | $15.99M | (m) | 4.50× |
| 2022-03-31 | $110.02M | $36.51M | (m) | (m) | $29.69M | $28.54M | $16.65M | (m) | 3.01× |
| 2021-12-31 | $113.27M | $31.89M | (m) | (m) | $24.44M | $28.41M | $14.47M | (m) | 3.55× |
| 2021-09-30 | $124.70M | $30.45M | (m) | (m) | $24.70M | $26.65M | $10.26M | (m) | 4.10× |
| 2021-06-30 | $128.18M | $27.27M | (m) | (m) | $23.09M | $23.95M | $10.02M | (m) | 4.70× |
| 2021-03-31 | $128.30M | $24.83M | (m) | (m) | $23.78M | $22.38M | $8.99M | (m) | 5.17× |
| 2020-12-31 | $132.30M | $25.90M | (m) | (m) | $19.13M | $23.21M | $9.72M | (m) | 5.11× |
| 2020-09-30 | $134.02M | $20.14M | (m) | (m) | $18.76M | $28.40M | $6.95M | (m) | 6.65× |
| 2020-06-30 | $136.42M | $20.55M | (m) | (m) | $17.14M | $29.06M | $8.29M | (m) | 6.64× |
| 2020-03-31 | $147.90M | $22.46M | (m) | (m) | $21.61M | $25.51M | $9.88M | (m) | 6.58× |
| 2019-12-31 | $95.84M | $23.24M | (m) | (m) | $22.77M | $28.66M | $10.37M | (m) | 4.12× |
| 2019-09-30 | $97.94M | $20.35M | (m) | (m) | $22.02M | $26.39M | $9.38M | (m) | 4.81× |
| 2019-06-30 | $84.18M | $21.39M | (m) | (m) | $21.31M | $26.54M | $8.53M | (m) | 3.94× |
| 2019-03-31 | $91.72M | $16.56M | (m) | (m) | $20.11M | $23.75M | $5.58M | (m) | 5.54× |
| 2018-12-31 | $99.44M | $16.45M | (m) | (m) | $17.65M | $24.84M | $6.24M | (m) | 6.05× |
| 2018-09-30 | $104.79M | $14.85M | $65.58M | (m) | $18.25M | $15.37M | $5.49M | (m) | 7.06× |
| 2018-06-30 | $45.34M | $18.77M | $11.64M | (m) | $16.20M | $13.22M | $7.47M | (m) | 2.42× |
| 2017-12-31 | $39.38M | $57.44M | $10.86M | (m) | $13.11M | $13.17M | $9.13M | (m) | 0.69× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |